Bruker tackles drugs of abuse and POPs issues
4 Jul 2024
At ASMS 2024, Bruker made two significant new technology announcements in the field of mass spectrometry, introducing products that can be implemented in diverse areas such as drugs of abuse screening, and persistent organic pollutants (POPs) analysis.
Watch Jeffrey Zonderman, Senior Vice President at Bruker introducing the EVOQ™ DART-TQ+, a new high-end triple quad, highlighted as a greener and more efficient alternative to chromatographic methods, to be used for targeted analysis. The ecTOF™, a high-resolution GC-MS, is also introduced, providing a new solution for untargeted high-resolution screening.
This video was filmed at ASMS 2024. Explore our full coverage of this year's conference >>
Related Products
Request Quote for All Products
ecTOF
Bruker DaltonicsThe ecTOF is the world’s first GC-HRMS with simultaneous acquisition of EI (Electron Ionization) and CI (Chemical Ionization) information in a single injection. While using EI as the gold-standard GC/MS ionization, the ecTOF in parallel operates a novel CI source. This way it simultaneously provides perfectly aligned accurate mass structural and molecular ion information within a single GC run.
